Veritas MyPrenatal NIPT Test
This podcast comprehensively introduces the non-invasive prenatal screening test (NIPT) called myPrenatal, developed by Veritas.
This podcast episode was prepared with AI assistance. The expressions in the content may occasionally have shortcomings or linguistic errors. The information here is for general informational purposes only; it does not constitute a diagnosis or treatment recommendation. For any evaluation and decision regarding your health condition, please consult your physician or Omega Genetik Diagnostic Evaluation Center.
About the Episode
The presented text comprehensively introduces the non-invasive prenatal screening test (NIPT) called myPrenatal, developed by Veritas. This technology aims to detect the baby's genetic health and possible chromosomal abnormalities at an early stage through a simple blood sample from the expectant mother. Using advanced sequencing methods and intelligent algorithms to minimize error rates, the system offers screening options ranging from Down syndrome to rare microdeletions. This test, which can be safely administered from the 10th week of pregnancy, eliminates the need for unnecessary interventions such as amniocentesis without posing any risk to the baby. In summary, the source details the technical operation, advantages, and different package options of this high-accuracy screening method offered by modern medicine, aiming to inform families. The text also emphasizes that this test is not a definitive diagnostic method but a risk assessment tool that should be evaluated with expert guidance.